A Study of SerpinPC in Participants with Hemophilia B (HemB) with Inhibitors

NCT05789537 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

3

Enrollment

INDUSTRY

Sponsor class

Stopped Study terminated due to business and strategic decision

Conditions

Hemophilia B with Inhibitor
Hemophilia B

Interventions

DRUG: SerpinPC

Sponsor

ApcinteX Ltd

Collaborators

[object Object]